Scar Prevention

12 registered clinical trials studyying Scar Prevention.

Status	Trial	Sponsor	Phase
Active Not Recruiting	Mepiform in Simultaneous Bilateral TKA NCT06312527	Thammasat University Hospital	N/A
Completed	A Study of Single Ascending Dose of LEM-S401 in Healthy Participants NCT04707131	Lemonex Inc.	Phase 1
Unknown	Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention NCT04722705	Hallym University Kangnam Sacred Heart Hospital	N/A
Terminated	Scar Prevention Using Fractional Carbon Dioxide Laser Treatment NCT01826942	Lumenis Be Ltd.	N/A
Completed	Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of NCT01780077	RXi Pharmaceuticals, Corp.	Phase 1
Completed	Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 NCT01640912	RXi Pharmaceuticals, Corp.	Phase 1
Completed	Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery NCT01037413	Pfizer	Phase 2
Completed	Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdomi NCT01037985	Pfizer	Phase 2
Completed	Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects U NCT01038297	Pfizer	Phase 2
Completed	A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of K NCT00892723	Capstone Therapeutics	Phase 2
Completed	A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars NCT00825916	Capstone Therapeutics	Phase 2
Completed	A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surger NCT00811577	Capstone Therapeutics	Phase 2